These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6819356)

  • 21. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro.
    Sharpe TJ; Ross JW; Spicer BA
    Agents Actions; 1978 Apr; 8(3):199-202. PubMed ID: 78665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by drugs of passive cutaneous anaphylaxis-induced skin histamine decrease.
    Yokoyama H; Shimamura K; Saeki K
    Acta Med Okayama; 1984 Aug; 38(4):357-65. PubMed ID: 6208752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-allergic activity of 7-acetyl-5-oxo-5H-[1] benzopyrano (2,3-b] pyridine (Y-9000) (author's transl)].
    Maruyama Y; Terasawa M; Goto K; Oe T
    Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):179-91. PubMed ID: 77826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M; Imayoshi T; Goto K
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum.
    Spicer BA; Ross JW; Sharpe TJ; Smith H
    Int Arch Allergy Appl Immunol; 1978; 56(6):493-9. PubMed ID: 415988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids.
    Wade JJ; Erickson EH; Hegel RF; Lappi LR; Rice TK
    J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selected immunologic properties of tiprinast, a non-steroidal antiallergy agent.
    Gillespie E; Dungan KW; Gomoll AW; Seidehamel RJ
    Int J Immunopharmacol; 1985; 7(5):655-60. PubMed ID: 2412976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
    Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (3).--Influence on homologous passive cutaneous anaphylaxis mediated by homocytotropic antibody (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):467-72. PubMed ID: 700511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The topical effects of Wy-41,195 [2-cyano-3-(methylamino)phenylamino] oxoacetic acid, sodium salt and disodium cromoglycate in the rat passive eyelid anaphylaxis.
    Carlson RP; O'Neill-Davis L; Lewis AJ
    Int Arch Allergy Appl Immunol; 1985; 76(1):89-90. PubMed ID: 3917983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain difference in an allergic asthma model in rats.
    Misawa M; Takenouchi K; Abiru T; Yoshino Y; Yanaura S
    Jpn J Pharmacol; 1987 Sep; 45(1):63-8. PubMed ID: 3119903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of passive lung anaphylaxis in the rat by AY-25,674.
    Greenberg R; Martel RR; Smorong K
    Can J Physiol Pharmacol; 1979 Jan; 57(1):48-52. PubMed ID: 106941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
    Revel L; Colombo S; Ferrari F; Folco G; Rovati LC; Makovec F
    Eur J Pharmacol; 1992 Dec; 229(1):45-53. PubMed ID: 1282105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.
    Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W
    Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an antiallergic agent (disodium cromoglycate) in rat conjunctiva using monoclonal IgE antibody.
    Tanaka H; Umemoto M; Miichi H; Hayashi S
    Ophthalmic Res; 1987; 19(4):240-4. PubMed ID: 3122141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H; Kohno S; Ohata K
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
    Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
    J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.